China Merchants China Direct Investments Invests RMB 15 Million in Neuracle Technology
China Merchants China Direct Investments Limited announced that its wholly-owned subsidiary, Shenzhen Tian Zheng Investment Co., Ltd., has entered into a share purchase agreement and related agreements dated 28 October 2025 to invest in Neuracle Technology (Shanghai) Co., Ltd. Under the terms of the deal, Tian Zheng agreed to contribute RMB 15 million as part of Neuracle Technology's Series E funding round. The capital contribution was completed on 7 November 2025. This investment aims to strengthen the company's portfolio in the medical sector, particularly in innovative brain-computer interface technology.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Merchants China Direct Investments Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251201-11935506), on December 01, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。